Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Supports no excess diabetes risk from thiazides after hypertension adjustment; leaves open causal questions for randomized trials.
Although thiazide diuretics and beta-blockers are often used as first-line therapy in patients with hypertension, including those with diabetes mellitus,1 the possibility that these drugs may promote glucose intolerance remains a concern.210 Short-term metabolic studies, as well as epidemiologic studies and clinical trials, suggested a causal link between the use of thiazide diuretics and the subsequent development of type 2 diabetes.310 However, those studies were compromised by small numbers of patients, relatively short follow-up periods, changing definitions of new-onset diabetes, lack of adequate comparison groups, selection criteria that lessened the extent to which the results could be generalized, . . .
No takes yet. Share an insight, caveat, or question.
Sowers et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: